Oracle Announces Release of Remote Data Capture 4.6
Oracle (Redwood Shores, CA) announced the release of Remote Data Capture 4.6. The company collaborated with customer advisors to develop additional functions for the EDC application. The latest additions include scalability improvements, flexible branching to support complex trial design (including for oncology trials), access restriction capabilities, and patient management enhancements.
Remote Data Capture is integrated with the company’s clinical data management system, Oracle Clinical.
“R&D efficiency, clinical effectiveness and time to market continue to be the greatest challenges facing life sciences organizations today,” said Neil de Crescenzo, Senior Vice President and General Manager, Oracle Health Sciences, in a company press release. “Oracle Remote Data Capture 4.6 provides strong evidence of our unwavering commitment to helping clinical trial sponsors and CROs accelerate insights for better health, and will enable our customers to complete clinical trials significantly faster and much more cost effectively than ever before.”
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.
